Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives
An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies.
